Q BioMed Inc. (QBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 4, 2026, 4:00 PM EST
Q BioMed Market Cap
Q BioMed has a market cap or net worth of $145 as of March 5, 2026. Its market cap has decreased by -99.80% in one year.
Market Cap
145.00
Enterprise Value
n/a
Revenue
209.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 17, 2015, Q BioMed's market cap has decreased from 12.19M to 145.00, a decrease of -100.00%. That is a compound annual growth rate of -65.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 14.51K | - |
| Dec 31, 2025 | 14.51K | 9,906.21% |
| Dec 31, 2024 | 145.00 | -99.75% |
| Dec 29, 2023 | 58.04K | -93.87% |
| Dec 30, 2022 | 947.29K | -92.38% |
| Dec 31, 2021 | 12.44M | -46.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobac Pharmaceuticals | 250.00 |
| NanoLogix | 163.00 |
| Poniard Pharmaceuticals | 150.00 |
| Seelos Therapeutics | 136.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |
| RVL Pharmaceuticals | 111.00 |
| Navidea Biopharmaceuticals | 100.00 |